therapy in the development of these cerebrovascular complications, which can occur at various stages
Kubenova, M.M.,
Balapanov, M.Kh.,
Kuterbekov, K.A.,
Akhmetgaliev, B.,
Ishembetov, R.Kh.,
Almukhametov, R.F.,
Zeleev, M.,
Kabyshev, A.M.,
Alina, R.,
Kondakirov, R.E.,
Kenzhebek, M.K. (2024) analysis, the synthesized samples are monoclinic jarleite Cu1.93÷1.97S with an admixture of
oxygen oxide Cu